K. Zander

Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology

P. W. Leeuw, A. Houben, K. Zander, 2005, Fundamental & clinical pharmacology.

Hypertension Exacerbates Coronary Artery Disease in Transgenic Hyperlipidemic Dahl Salt-sensitive Hypertensive Rats

V. Herrera, D. Gantz, L. Lopez, 2001, Molecular medicine.

C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo.

J. Floege, K. Koch, J. Floege, 1998, Kidney international.

Fermented lactotripeptides-containing milk lowers daytime blood pressure in high normal-to-mild hypertensive subjects

M. Jäkel, K. Zander, M. Koning, 2008, Journal of Human Hypertension.

Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide.

A. Kroon, P. D. de Leeuw, P. W. Leeuw, 1999, Cardiovascular research.

Nitric oxide dependence of renal blood flow in patients with renal artery stenosis.

J. V. van Engelshoven, A. Kroon, P. D. de Leeuw, 2001, Journal of the American Society of Nephrology : JASN.

Selective endothelin B receptor blockade does not influence BNP-induced natriuresis in man.

D. Webb, P. D. de Leeuw, L. Hofstra, 2006, Kidney international.